Skip to content

Series B Financing

After the recent announcement of the Series Seed Financing documents by Marc Andreesen, Brad Feld points out that there are now four sets of “open source” equity seed financing documents:

$16M Series B Financing to Fund Phase 2 Study of AYX1 for the Prevention of Chronic Pain Following Surgery. SAN FRANCISCO, Calif., January 9, 2017 – Adynxx, developer of a first-in-class platform of therapeutics for the prevention and resolution of chronic pain, today announced that the company raised $16 million in a.

Apr 08, 2018  · Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced the company has raised $30.5 million in an oversubscribed Series B financing.

Neurelis, Inc. today announced that it has finalized a Series B financing round led by HBM Healthcare Investments. In addition, LYZZ Capital, which led the Series A funding for Neurelis, has participated in the Series B round.

rfXcel Raises $30 Million in Series B Financing. rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners. Kayne Partners is the growth private equity group of Kayne Anderson Capital Advisors, L.P., an alternative.

Mojio Inc has raised $30 million in a Series B financing. The round was led by Kensington Capital Partners. It was joined by Trend Forward Capital and innogy Ventures, both new investors, and Amazon Alexa Fund, BDC Capital’s IT Venture Fund, Deutsche Telekom and Relay Ventures, which invested in last year’s Series A round.

raised $24 million in Series B financing led by automotive giant Cox Automotive — owner of AutoTrader, Kelley Blue Book and Manheim Auctions. Other participating investors in the round include Menlo Ventures, Triangle Peak Partners, and SOS. Ventures. This latest round of investment brings Getaround's total funding to.

Jan 23, 2018  · Big data systems tend to be large, complex and often hard to troubleshoot. In the world of databases, web and mobile stacks, application performance management services like AppDynamics and New Relic help ops teams keep tabs on.

Founded and headquartered in New York City, Kallyope is developing an industry-leading platform to harness the gut-brain axis.

Ascletis announced it has successfully completed US$100 million (RMB 700 million) series B financing. The investment was led by C-Bridge Capital, joined by a number of new investors including QianHai Equity Investment FOF, FOCUS Media Jiangnanchun Foundation, WTT Investment, together with the current investors Goldman Sachs,

Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis

Volantio secures $2.6 million Series B financing. February 12, 2018. Financing led by Ingleside Investors with strategic investors International Airlines Group, JetBlue Technology Ventures, and Qantas Ventures. Azim Barodawala, Volantio co-founder. Volantio, a global leader in post-booking revenue and capacity.

AirDoc, the leader in artificial intelligence for healthcare, announced that it has completed a Series B financing led by.

PALO ALTO, Calif., April 09, 2018 (GLOBE NEWSWIRE) — Plus Products, the cannabis infused products manufacturer, announced today that it has closed approximately $6M in Series B financing to expand its operations and satisfy.

SUZHOU, China, April 02, 2018 (GLOBE NEWSWIRE) — CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for.

Cultiva LLC Raises Series B Financing. LAS VEGAS–(BUSINESS WIRE)–Cultiva LLC, maker of Parka®, a patented food-grade biofilm, raised $1.9 MM in a Series B financing round. The capital, raised in conjunction with the Nevada New Markets Tax Credit Program, will help Cultiva continue its rapid growth and expand its.

A series A round is the name typically given to a company’s first significant round of venture capital financing.The name refers to the class of preferred stock sold to investors in exchange for their investment.

China’s XPENG Motors Monday kicked off a RMB2.2 billion Series B round of funding backed by Alibaba Group, Foxconn and IDG Capital. Alibaba was a key backer of the Guangzhou-based electric-car company’s round A+ financing and remains a major investor in this Series B round for XPENG, which is.

Series A and B Financing Series A financing is defined as the first round for a new business venture after seed capital. Generally, this is the first time that company ownership is offered to external investors. Series A financing may be provided in the form of preferred stock and may offer anti-dilution provisions in.

Series B. —. Apr 6, 2018. 10. Series B – BayoTech, Inc · BayoTech, Inc. Series B. $12,500,000. Apr 6, 2018. 11. Series A – Koudaibaobao · Koudaibaobao. Series A. —. Debt Financing. ₹550,000,000. Apr 6, 2018. 20. Grant – Steam Whistle · Steam Whistle. Grant. $1,300,000. Apr 6, 2018. 21. Venture Round – hearX Group.

BayoTech, Inc., an Albuquerque, NM-based developer of advanced chemical reactors for the distributed production of hydrogen and fertilizers, closed a.

MILPITAS, Calif.–(BUSINESS WIRE)–Bigfoot Biomedical, Inc., a diabetes solutions company harnessing the power of artificial intelligence to optimize the dosing and delivery of insulin for people with insulin-requiring diabetes, today.

Raising a Series B financing is a major milestone in the life of a company. However, from the negotiation of the term sheet to the closing process, you will face a set of issues that is unlike what you experienced in the Series A financing. Here are some issues to keep in mind about Series B financings, some of which are.

SAN FRANCISCO–(BUSINESS WIRE)–Tempest Therapeutics Inc., a development-stage biotechnology company advancing small molecules that modulate anti-tumor immunity pathways, today announced the completion of a $70.

Vaccine Spin-off from Sutro Biopharma to Utilize Site-Specific Conjugation Technology. South San Francisco, CA, July 23, 2015 – SutroVax, a recently established biopharmaceutical vaccine company, today announced the completion of a $22 million Series A financing.

* POSEIDA THERAPEUTICS SAYS IN CONJUNCTION WITH FINANCING, DAVID HIRSCH, MANAGING DIRECTOR AT LONGITUDE CAPITAL, JOINED POSEIDA’S BOARD Source text for Eikon: Our Standards:The Thomson Reuters Trust.

Asilomar Bio, a San Francisco-based maker of chemical crop inputs has raised a $12.25 million Series B Round to bring it’s first chemical yield enhancement product to market. This announcement comes on the heels of a licensing agreement with Koch Biological Solutions, which has secured global.

At Greylock, my partners and I are driven by one guiding mission: always help entrepreneurs. It doesn’t matter whether an entrepreneur is in our portfolio, whether we’re considering an investment, or whether we’re casually meeting for the first time.

Logo Of State Bank Of India The World Bank Group works in every major area of development. We provide a wide array of financial products and technical assistance, and we help

BayoTech has made a significant score in funding. The Albuquerque-based developer of advanced chemical reactors has closed a $12.5 million Series B.

PEAR Therapeutics Completes $50 Million Series B Financing Temasek Joins Current Investors to Advance Prescription Digital Therapeutics Platform

Car Loan 4 You Talk to your car dealership. Car dealerships usually do not have the best loan rates; however, it is worth it to see what they have

PORTLAND, Oregon—(January 2018)—ZincFive, an intelligent energy storage and delivery solutions company announced it has raised $11 million in Series B funding from existing and new investors. The investment brings ZincFive's total funding since inception to $14 million. The proceeds are being used to enable the.

ALBUQUERQUE, N.M., April 6, 2018 /PRNewswire/ — BayoTech, Inc., developer.

* FINANCING LED BY RA CAPITAL MANAGEMENT AND BRIDGEBIO PHARMA, JANUS HENDERSON, VIKING GLOBAL INVESTORS, AMONG OTHERS Source text for Eikon: Our Standards:The Thomson Reuters Trust Principles.

Baird Capital portfolio company Amphora Medical, Inc., a Minneapolis-based developer of medical devices to treat overactive bladder (OAB), announced today the closing of a $35.5 million Series B financing.

CAMBRIDGE, Mass., January 4, 2016 – Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment, today announced a $36 million Series B financing. Fidelity Management and Research Company.

Oct 05, 2017  · Gobble, a 15-minute meal kit delivery service, has raised $15 million in Series B growth financing from Khosla Ventures, TechCrunch has confirmed. Khosla Ventures led the round, along with participation from previous investors A16z, Trinity Ventures and Initialized Capital.

Mar 23, 2018. NEW YORK, NY, Digitally powered short-distance aviation leader has completed its Series B Financing.

Feb 15, 2018. RA'ANANA, Israel, February 15, 2018 /PRNewswire/ –. SMART Medical Systems Ltd., a manufacturer of innovative gastro-intestinal endoscopy products, announced today that it secured US$8 million in series B financing. The financing round was led by Signet Healthcare Partners, a NY-based healthcare.

SAN FRANCISCO – (BUSINESS WIRE) – Keen IO, the leader in cloud analytics, today announced it has closed $14.7 million in a Series B financing round. This funding brings Keen's total capital raised to date to approximately $30 million and supports the company's accelerating global growth in the enterprise. Keen now.

Eidos Therapeutics, Inc., a San Francisco, CA-based clinical stage biopharmaceutical company developing a novel oral therapy to treat.

DUBLIN – Tempest Therapeutics Inc. raised $70 million in a series B round to progress four small-molecule drug development programs addressing different aspects of immunometabolism in the tumor microenvironment.

6 days ago. On March 31st, YOUXIA Motors announced its completion of Series B financing at a press conference, revealing the company's financing information for the first time since its establishment in 2013. This round of funding brought in 5 billion yuan ($793M), co-invested by twelve institutions including China.

* POSEIDA THERAPEUTICS SAYS IN CONJUNCTION WITH FINANCING, DAVID HIRSCH, MANAGING DIRECTOR AT LONGITUDE CAPITAL, JOINED POSEIDA’S BOARD Source text for Eikon: Our Standards:The Thomson Reuters Trust.

Perfect Credit Card A survey by lender SocietyOne found that of the Aussies who took out a balance transfer card to help pay off their debt faster, 67

Bigfoot Biomedical, Inc., a diabetes solutions company harnessing the power of artificial intelligence to optimize the dosing and delivery of insulin for people with insulin-requiring diabetes, today announced that the company has.

Stock Screening Here at MarketBeat, we like dividends. But we know that tracking down payers that could potential boost payouts can be tricky for retail investors. There

Mar 1, 2018. Finch Therapeutics Group, Inc. (Finch), a privately held microbiome therapeutics company, announced today the successful close of an oversubscribed $36 million Series B financing, bringing the total capital raised since the Company's launch to $77 million.

Orrick has advised HashiCorp., a San Francisco-based open-source software startup, in its $24 million Series B financing round.

Mar 13, 2018. BRIEF-Crinetics Pharma Completes $63.5 Mln Series B Financing. Reuters Staff. 1 Min Read. March 13 (Reuters) – Crinetics Pharmaceuticals: * CRINETICS PHARMACEUTICALS COMPLETES $63.5 MILLION SERIES B FINANCING. * CRINETICS PHARMA, A RARE DISEASE THERAPEUTICS CO, SAYS.

Soylent Closes $50 Million Series B Round Led by GV Soylent today announced the completion of a $50 million Series B financing round led by GV (formerly Google Ventures) with participation from Tao.

* SAYS SERIES B EQUITY FINANCING BRINGS TOTAL AMOUNT OF EQUITY RAISED BY CO TO OVER $90 MILLION Source text for Eikon: Our Standards:The Thomson Reuters Trust Principles.